This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 11817252

PUBLISHED SUBJECT

SPMS (2023/304) ENOXAPARINA

Parties involved

Place of performance
Portugal, Coimbra, Coimbra
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
LAB. FARMACEUTICOS ROVI, SA. · Tax ID 980166705
Bidder
SANOFI- PRODUTOS FARMACÊUTICOS,LDA. · Tax ID 500134960
Bidder
LAB. ATRAL SA · Tax ID 500162085

Values and timeline

Contract price
€10,813.50
Procedure base price
€0.00
Total effective price
€3,472.00
Publication date
22 October 2025
Award date
20 December 2024
Signing date
1 January 2025
Performance period
365 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Monofator
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
Framework agreement
304/2023 - Medicamentos do grupo 4: sangue
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
7865028

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts